Stock Market 26 May 2026 - 27 May 2026

Voyager Therapeutics Stock Is Waking Up Before a Make-or-Break Tau Window

Voyager Therapeutics Stock Is Waking Up Before a Make-or-Break Tau Window

Voyager Therapeutics shares rose 4 cents to $3.83 in thin premarket trading, valuing the company at $228 million. H.C. Wainwright reiterated a Buy rating and $25 target, citing upcoming milestones including first human dosing for VY1706 and tau PET imaging data for VY7523 in the second half of 2026. Voyager reported $171.7 million in cash at the end of Q1.
May 27, 2026
Zenas BioPharma Stock Slips as a June Catalyst Moves Into View

Zenas BioPharma Stock Slips as a June Catalyst Moves Into View

Zenas BioPharma shares fell 1.3% to $18.73 on Tuesday, underperforming the biotech sector ahead of a June 4 presentation of Phase 3 data for its autoimmune drug obexelimab. The trial showed a 56% reduction in IgG4-RD flare risk, below Amgen’s Uplizna, which cut risk by 87%. Zenas plans to seek FDA approval this quarter. Investors remain cautious as the stock trades well below its 52-week high.
May 27, 2026
Plains GP Stock Drops After Holiday Break — What the Move Signals Now

Plains GP Stock Drops After Holiday Break — What the Move Signals Now

Plains GP Holdings LP shares fell 1.7% to $25.51 Tuesday, underperforming the broader market as pipeline stocks slipped after the Memorial Day break. No new company news was posted, with the latest update remaining the May 12 sale of its Canadian NGL business for $3.3 billion. Plains All American Pipeline dropped 2.4%. PAGP traded near the top of its 52-week range.
May 26, 2026
Travelzoo Gains as Shares Tick Higher, Traders Look at the Small Cap

Travelzoo Gains as Shares Tick Higher, Traders Look at the Small Cap

Travelzoo shares rose 0.8% to $10.11 in late Nasdaq trading Tuesday after U.S. markets reopened from the Memorial Day holiday. The company last reported first-quarter revenue of $24.3 million, up 5% year over year, and earnings per share of 23 cents. Operating income slipped to $3.45 million as sales and marketing costs increased. Trading volume reached about 89,600 shares.
May 26, 2026
NeuroSense trades close to 90 cents as next $1 Nasdaq threshold comes into view

NeuroSense trades close to 90 cents as next $1 Nasdaq threshold comes into view

NeuroSense Therapeutics shares rose 5 cents to 87 cents Tuesday, staying below Nasdaq’s $1 minimum bid price. The company faces delisting risk, needing its stock to close above $1 and its market value to reach $35 million for 10 days by Sept. 29, 2026. NeuroSense recently raised $600,000 in a private share sale. Its ALS drug candidate, PrimeC, is set for Phase 3 trials after FDA clearance.
May 26, 2026
Pilgrim’s Pride lags as Nasdaq rallies; margin risk in focus

Pilgrim’s Pride lags as Nasdaq rallies; margin risk in focus

Pilgrim’s Pride shares fell 1.2% to $28.13 in early afternoon trading Tuesday, underperforming gains in the broader U.S. market. The drop followed first-quarter results showing net sales up 1.6% but GAAP earnings per share down 65.3%. About 430,000 shares traded, with the company’s market cap near $6.7 billion. Investors remain focused on pressured chicken margins after a quiet holiday weekend.
May 26, 2026
CEPT Stock Sits Quiet, But Cantor Equity Partners II Keeps Some Attention

CEPT Stock Sits Quiet, But Cantor Equity Partners II Keeps Some Attention

Cantor Equity Partners II Inc. fell 2 cents to $12.95 Tuesday as traders watched its planned merger with Securitize. About 433,600 shares traded in a $12.75–$13.05 range, putting market cap near $396 million. CEPT’s price stayed above its $10 IPO level, reflecting interest in the Securitize deal. The merger still faces shareholder approval and regulatory hurdles.
May 26, 2026
Value Line Stock Ticks Higher After Holiday, But With Light Volume

Value Line Stock Ticks Higher After Holiday, But With Light Volume

Value Line (VALU) shares rose 0.8% to $33.25 in thin Tuesday morning trading, with just 127 shares changing hands. The company reported nine-month net income of $18.1 million, up 7.9%, but publishing revenue fell 4.7%. Value Line raised its quarterly dividend to 35 cents in April, yielding about 4.2%. No new company news was reported during the session.
May 26, 2026
Happy City Stock Jumps After Nasdaq Reopening, Traders Eye $20 Million Equity Line

Happy City Stock Jumps After Nasdaq Reopening, Traders Eye $20 Million Equity Line

Shares of Happy City Holdings rose about 5% to $3.62 in late-morning Nasdaq trading Tuesday after the U.S. market reopened post-Memorial Day. The Hong Kong hotpot chain’s stock remains down 28% from its June 2025 IPO. Happy City disclosed a standby equity purchase agreement for up to $20 million in new shares. Annual revenue fell 18% to $6.80 million, with a net loss of $2.43 million.
May 26, 2026
Baozun Shares Rise After Holiday Reopening With Turnaround Still in Focus

Baozun Shares Rise After Holiday Reopening With Turnaround Still in Focus

Baozun Inc. ADSs rose 2.8% to $2.57 in early Nasdaq trading Tuesday, outpacing larger China internet stocks after reopening from the Memorial Day holiday. The move followed last week’s earnings, where Baozun posted a first-quarter swing to a slim non-GAAP operating profit and 15.3% revenue growth. Operating margin was 0.01%, with a net loss to ordinary shareholders. Director Bin Yu received 24,000 RSUs on May 21.
May 26, 2026
Elmet shares steady ahead of earnings as new filing hits market

Elmet shares steady ahead of earnings as new filing hits market

Elmet Group said in an SEC filing it switched to a 4-4-5 fiscal year, starting Jan. 1, 2026, replacing its Dec. 31 close. Shares traded at $14.70 before Tuesday’s Nasdaq open, up slightly from the IPO price. The company reports first-quarter results Friday, its first earnings call since going public in April. Elmet raised about $125.5 million in its IPO last month.
May 26, 2026
CEA Industries stock jumps ahead of open as 10X battle heats up

CEA Industries stock jumps ahead of open as 10X battle heats up

CEA Industries sued asset manager 10X Capital in Delaware, seeking to void their agreement and recover fees. CEA shares rose 1.5% to $2.67 in light pre-market trading after the news. The company faces Nasdaq delisting risk over a missed annual meeting and disclosed a $10 million loan backed by BNB, which has dropped in value. CEA reported a $106.6 million quarterly net loss, citing BNB’s price decline.
May 26, 2026
TransMedics Stock Has a Post-Holiday Test — The Next Catalyst Is Already on the Calendar

TransMedics Stock Has a Post-Holiday Test — The Next Catalyst Is Already on the Calendar

TransMedics Group shares traded at $68.94 in premarket Tuesday, up 0.2% after the Memorial Day break, valuing the company near $2.5 billion. The move followed a May earnings report showing 21% revenue growth but a sharp drop in net income to $7.3 million. No new company news was posted after May 21. Wall Street analysts cut price targets earlier in May but mostly kept positive ratings.
May 26, 2026
1 6 7 8 9 10 127

Stock Market Today

  • Tesco's Strategic Shift to Data and Media Could Propel Shares Higher
    June 2, 2026, 8:56 AM EDT. Tesco shares have plateaued at around 440p, down 12.6% from February highs, despite a solid 2025 performance with £73.7bn revenue and £3.15bn operating profit. The retailer is evolving beyond groceries, leveraging its Clubcard loyalty scheme covering 24 million UK households to build a robust retail media and data business. Tesco Media & Insight Platform reaches 58% of the UK population weekly, rivaling Facebook's media reach. CEO Ken Murphy anticipates retail media will significantly boost profits in the medium term. Recurring revenue streams now include a £7.99/month Clubcard Plus subscription and data partnerships with firms like The Trade Desk and Channel 4, positioning Tesco as a hybrid grocer and media company.